
April 18, 2025
Safety
New
PMDA Risk Communication: Onasemnogene abeparvovec posted
April 18, 2025
Safety
New
PMDA Risk Communication: Acetazolamide, etc. posted
April 18, 2025
Review
New
“Initiatives to Promote Pediatric Drug Development” posted
April 14, 2025
Review
Information on biosimilars is updated
April 11, 2025
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.418 posted
April 11, 2025
Review
List of Approved Products (New Drugs): April 2004 to December 2024
April 11, 2025
Other
Recent Publications by PMDA Staff updated
April 9, 2025
JP
Implementation of ICH-Q3D into Japanese Pharmacopoeia updated
Currently, there is no applicable information.
Currently, there is no applicable information.